Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,694 | -21,102 | -39,474 | -20,913 | -23,877 |
| Depreciation Amortization | 41 | 30 | 22 | 10 | 1,603 |
| Accounts payable and accrued liabilities | -165 | -1,034 | 1,023 | -1,677 | -1,822 |
| Other Working Capital | -669 | -478 | -571 | -1,649 | -13,630 |
| Other Operating Activity | 2,144 | 3,249 | 2,852 | 4,195 | 1,745 |
| Operating Cash Flow | $-4,343 | $-19,335 | $-36,148 | $-20,034 | $-35,981 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -47 | -36 | -23 | -7 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 13,017 |
| Sale Of Investment | N/A | N/A | N/A | 4,500 | 19,500 |
| Investing Cash Flow | $N/A | $-47 | $-36 | $4,477 | $32,510 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 437 | 7,397 |
| Debt Repayment | N/A | N/A | N/A | N/A | -4,808 |
| Common Stock Issued | 6,569 | 1,233 | 33,004 | 38,003 | 47 |
| Other Financing Activity | -38 | -55 | -51 | 0 | 0 |
| Financing Cash Flow | $6,531 | $1,178 | $32,953 | $38,440 | $2,636 |
| Beginning Cash Position | 8,680 | 26,884 | 30,115 | 7,232 | 8,067 |
| End Cash Position | 10,868 | 8,680 | 26,884 | 30,115 | 7,232 |
| Net Cash Flow | $2,188 | $-18,204 | $-3,231 | $22,883 | $-835 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,343 | -19,335 | -36,148 | -20,034 | -35,981 |
| Capital Expenditure | N/A | -47 | -36 | -23 | -7 |
| Free Cash Flow | -4,343 | -19,382 | -36,184 | -20,057 | -35,988 |